Lynda Charters

Speaking at the American Academy of Optometry 2021 annual meeting in Boston, Anthony DeWilde, OD, FAAO, discussed biologics, which hold promise for the treatment of ophthalmic diseases.

Brain fog and cognitive impairment symptoms observed months after infection.

The in-person event is scheduled for November 3 to 6 at the Boston Convention and Exhibition Center, with a Best of Academy 2021 Boston virtual meeting scheduled for December 3 to 5.

Disease masquerading as involutional ptosis

Approval may kickstart vaccination effort

Cutoff age for evaluation: 66 years

Use of a drug to correct the eyelid position could eliminate the complications associated with surgery.

Perhaps the most important consideration is understanding the neuromuscular pathway that retracts and protracts the eyelid.

Use of nepafenac may decrease macular volume more rapidly after surgery to repair epiretinal membranes.

Olopatadine hydrochloride ophthalmic solution 0.2%, a combination mast cell stabilizer and antihistamine, effectively relieves the itching associated with allergic conjunctivitis with once-daily dosing.